[Clinical study on 57 cases with caesarean scar pregnancy].
OBJECTIVE
To investigate treatment of caesarean scar pregnancy (CSP) and associated problem.


METHODS
From January 2011 to January 2013, 57 cases with CSP undergoing treatment in Affiliated Hospital of Hebei University were studied retrospectively. Among 57 patients, it was divided into 12 cases treated by curettage (curettage group); 22 cases treated by uterine artery embolization(embolization group);8 cases treated by laparotomy(laparotomy group) and 15 cases treated by transvaginal debridement(transvaginal group).


RESULTS
(1)Successful rate of curettage group, embolization group, laparotomy group and transvaginal group were 12/12, 86% (19/22), 7/8, 13/15. (2) The intraoperative blood loss and the hospital stay were 20 (17-28) ml,(5.1 ± 1.9) days in curettage group, 10 (5-15) ml, (10.2 ± 3.2) days in embolization group, 200 (80-300) ml, (11.3 ± 3.3) days in laparotomy group, 50 (45-100) ml, (6.8 ± 1.2) days in transvaginal group. There was statistically different between curettage group and embolization group (P < 0.05). There was statistically different between laparotomy group and transvaginal group (P < 0.05).


CONCLUSIONS
Curettage, uterine artery embolization, abdominal and transvaginal scar debridement surgery can be used in treatment of the CSP. It should be carefully chosen with surgical intervention, if myometrium was implanted greater than 1/2, or near to serosa.It should be carefully chosen with vaginal surgery, if the blood flow signals was rich around the lesion.
Department of Obstetrics and Gynecology, Affiliated Hospital of Hebei University, Baoding 071000, China.
Junrong
J
Shi
Department of Obstetrics and Gynecology, Affiliated Hospital of Hebei University, Baoding 071000, China. Email: qinjinjin_1@163.com.
Jinjin
J
Qin
Department of Obstetrics and Gynecology, Affiliated Hospital of Hebei University, Baoding 071000, China.
Weiming
W
Wang
Department of Obstetrics and Gynecology, Affiliated Hospital of Hebei University, Baoding 071000, China.
Hui
H
Zhang
D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D002921:Cicatrix / Q000150:complications* / Q000000981:diagnostic imaging; D003475:Curettage; D005260:Female; D006801:Humans; D007813:Laparotomy; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*; D012189:Retrospective Studies; D016896:Treatment Outcome; D016216:Ultrasonography, Prenatal; D055357:Uterine Artery Embolization; D014592:Uterine Hemorrhage / Q000209:etiology / Q000601:surgery; D014599:Uterus / Q000098:blood supply / Q000000981:diagnostic imaging / Q000601:surgery
D018997:Chorionic Gonadotropin, beta Subunit, Human